HeartSciences (HSCS) Proxy filing summary

Executive summary

• Announced filing of the annual report for fiscal year ended April 30, 2026, and upcoming preliminary proxy statement for a proposed merger with Fortitude Mining Holdings, Inc.

• The proposed transaction is expected to provide shareholders with ownership in a larger, revenue-generating business and allow continued development of MyoVista Insights AI-ECG technology.

• Fiscal 2026 marked the launch of MyoVista Insights and a transition to mainstream commercial revenue.

• A detailed proxy statement and business update, including fiscal 2026 earnings, are expected to be released shortly.

• Forward-looking statements highlight potential benefits and risks, including transaction completion, integration, and market conditions.

Voting matters and shareholder proposals

• Shareholders will be asked to vote on the proposed merger with Fortitude Mining Holdings, Inc. at a special meeting.

• Proxy materials, including a preliminary and definitive proxy statement, will be mailed to shareholders of record.

Board of directors and corporate governance

• Directors and executive officers of both companies, as well as certain DCG executives, may be deemed participants in the proxy solicitation.

• Information about directors, executive officers, and their interests will be disclosed in the proxy statement and related SEC filings.